OncoRes Medical Awarded $3 Million CRC-P Grant to Advance Precision Prostate Cancer Surgery
OncoRes Medical has been awarded $3 million in funding under the Australian Government’s Cooperative Research Centres Projects (CRC-P) program to explore the application of the Company’s proprietary Quantitative Micro-Elastography (QME) imaging technology in prostate cancer surgery.
Prostate cancer affects approximately 1.5 million men globally each year. Treatment options may include focal therapy or radical prostatectomy. Through this CRC-P project, we will investigate the potential role QME could play in improving patient outcomes across both treatment options.
